Suppr超能文献

激肽释放酶相关肽酶(KLKs)与血栓形成轴的功能交集。

Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.

机构信息

Department of Biomedical Sciences, Florida State University, Tallahassee, 32306-4300, USA.

出版信息

Biol Chem. 2010 Apr;391(4):311-20. doi: 10.1515/BC.2010.024.

Abstract

A large body of emerging evidence indicates a functional interaction between the kallikrein-related peptidases (KLKs) and proteases of the thrombostasis axis. These interactions appear relevant for both normal health as well as pathologies associated with inflammation, tissue injury, and remodeling. Regulatory interactions between the KLKs and thrombostasis proteases could impact several serious human diseases, including neurodegeneration and cancer. The emerging network of specific interactions between these two protease families appears to be complex, and much work remains to elucidate it. Complete understanding how this functional network resolves over time, given specific initial conditions, and how it might be controllably manipulated, will probably contribute to the emergence of novel diagnostics and therapeutic agents for major diseases.

摘要

大量新出现的证据表明,激肽释放酶相关肽酶(KLKs)与血栓形成轴的蛋白酶之间存在功能相互作用。这些相互作用似乎与正常健康以及与炎症、组织损伤和重塑相关的病理学都有关。KLKs 和血栓形成蛋白酶之间的调节相互作用可能会影响几种严重的人类疾病,包括神经退行性疾病和癌症。这两种蛋白酶家族之间特定相互作用的新兴网络似乎很复杂,还有很多工作要做才能阐明这一点。完全了解这个功能网络在特定初始条件下随时间如何解决,以及如何对其进行可控操作,可能有助于为重大疾病开发新的诊断和治疗药物。

相似文献

1
2
Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Protein Sci. 2008 Nov;17(11):1998-2007. doi: 10.1110/ps.036715.108. Epub 2008 Aug 12.
3
Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Biol Chem. 2013 Jan;394(1):137-47. doi: 10.1515/hsz-2012-0249.
4
Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
Biol Chem. 2018 Sep 25;399(9):937-957. doi: 10.1515/hsz-2018-0111.
5
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Expert Opin Ther Targets. 2016 Jul;20(7):801-18. doi: 10.1517/14728222.2016.1147560. Epub 2016 Mar 4.
6
Targeting the kallikrein-related peptidases for drug development.
Trends Pharmacol Sci. 2012 Dec;33(12):623-34. doi: 10.1016/j.tips.2012.09.005. Epub 2012 Oct 19.
7
Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
Biol Chem. 2010 Apr;391(4):299-310. doi: 10.1515/BC.2010.038.
8
Functional roles of human kallikrein-related peptidases.
J Biol Chem. 2009 Nov 27;284(48):32989-94. doi: 10.1074/jbc.R109.027946. Epub 2009 Oct 9.
10
Interdependence of kallikrein-related peptidases in proteolytic networks.
Biol Chem. 2010 May;391(5):581-7. doi: 10.1515/BC.2010.055.

引用本文的文献

2
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.
Nat Rev Cancer. 2022 Apr;22(4):223-238. doi: 10.1038/s41568-021-00436-z. Epub 2022 Jan 31.
3
Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.
J Neuropathol Exp Neurol. 2013 Nov;72(11):1072-89. doi: 10.1097/NEN.0000000000000007.
4
Induction of complement C3a receptor responses by kallikrein-related peptidase 14.
J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6.
5
Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6.
Chem Cent J. 2012 Dec 5;6(1):148. doi: 10.1186/1752-153X-6-148.
6
Protease-armed bacteria in the skin.
Cell Tissue Res. 2013 Feb;351(2):325-37. doi: 10.1007/s00441-012-1355-2. Epub 2012 Feb 23.
7
Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Tumour Biol. 2012 Aug;33(4):1075-84. doi: 10.1007/s13277-012-0347-x. Epub 2012 Feb 21.
8
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
Am J Pathol. 2011 Nov;179(5):2625-36. doi: 10.1016/j.ajpath.2011.07.016. Epub 2011 Sep 9.
9
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
Biochimie. 2010 Nov;92(11):1546-67. doi: 10.1016/j.biochi.2010.06.022. Epub 2010 Jul 6.

本文引用的文献

1
Functional roles of human kallikrein-related peptidases.
J Biol Chem. 2009 Nov 27;284(48):32989-94. doi: 10.1074/jbc.R109.027946. Epub 2009 Oct 9.
2
SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor.
J Invest Dermatol. 2009 Jul;129(7):1656-65. doi: 10.1038/jid.2008.448. Epub 2009 Feb 5.
5
Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.
Histol Histopathol. 2009 Feb;24(2):197-207. doi: 10.14670/HH-24.197.
6
Proteinases as hormones: targets and mechanisms for proteolytic signaling.
Biol Chem. 2008 Aug;389(8):971-82. doi: 10.1515/BC.2008.120.
7
Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.
J Neurochem. 2008 Nov;107(3):855-70. doi: 10.1111/j.1471-4159.2008.05658.x. Epub 2008 Sep 6.
8
Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Protein Sci. 2008 Nov;17(11):1998-2007. doi: 10.1110/ps.036715.108. Epub 2008 Aug 12.
10
Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids.
Biol Chem. 2008 Jun;389(6):747-56. doi: 10.1515/BC.2008.086.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验